Table 1 |
|||
|
Demographic, laboratory and clinical data for the RA patient group (n = 143) |
|||
|
Parameters |
Data |
Median [IQR] |
Range |
|
|
|||
|
Age (years) |
48 ± 12 |
48 [41 to 56] |
20 to 75 |
|
Females, n (%) |
118 (82.5%) |
||
|
Blacks, n (%) |
124 (86.7%) |
||
|
DAS28-CRP |
5.6 ± 1.3 |
5.7 [4.8 to 6.7] |
2.3 to 8.7 |
|
Disease duration (months) |
12 ± 7 |
10 [6 to 18] |
0 to 25 |
|
Larsen radiographic scores |
23 ± 14 |
19 [14 to 28] |
1 to 66 |
|
RF (IU/ml) |
490 ± 795 |
168 [38 to 595] |
4 to 5,350 |
|
aCCP (U/ml) |
669 ± 636 |
492 [85 to 1,099] |
2 to 2,527 |
|
CRP (μg/L) |
24 ± 32 |
14 [5 to 32] |
0 to 198 |
|
SAA (μg/ml) |
62 ± 123 |
14 [5 to 65] |
1 to 882 |
|
|
|||
|
aCCP = anticyclic citrullinated peptide antibodies; CRP = C-reactive protein; DAS28 = Disease Activity Score in 28 joints; RF = rheumatoid factor; SAA = serum amyloid A. Data are means ± SD, n (%), medians [25th to 75th IQR] or raw data as indicated. |
|||
|
Meyer et al. Arthritis Research & Therapy 2011 13:R160 doi:10.1186/ar3479 |
|||